Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-1-4
pubmed:abstractText
Evidence on cost-effectiveness is important to make well-informed decisions regarding care delivery.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1472-1465
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
198
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
59-65, sup 1
pubmed:dateRevised
2011-6-15
pubmed:meshHeading
pubmed-meshheading:21200078-Activities of Daily Living, pubmed-meshheading:21200078-Adolescent, pubmed-meshheading:21200078-Adult, pubmed-meshheading:21200078-Cognitive Therapy, pubmed-meshheading:21200078-Cost-Benefit Analysis, pubmed-meshheading:21200078-Female, pubmed-meshheading:21200078-Health Care Costs, pubmed-meshheading:21200078-Hospitalization, pubmed-meshheading:21200078-Humans, pubmed-meshheading:21200078-Male, pubmed-meshheading:21200078-Middle Aged, pubmed-meshheading:21200078-Outcome Assessment (Health Care), pubmed-meshheading:21200078-Psychiatric Status Rating Scales, pubmed-meshheading:21200078-Psychotic Disorders, pubmed-meshheading:21200078-Recurrence, pubmed-meshheading:21200078-Schizophrenia, pubmed-meshheading:21200078-Schizophrenic Psychology, pubmed-meshheading:21200078-Time Factors, pubmed-meshheading:21200078-Young Adult
pubmed:year
2011
pubmed:articleTitle
Cognitive-behavioural therapy for persistent and recurrent psychosis in people with schizophrenia-spectrum disorder: cost-effectiveness analysis.
pubmed:affiliation
VU University and EMGO Institute, Department of Clinical Psychology, Van der Boechorststraat 1, 1081 BT Amsterdam, The Netherlands. m.van.der.gaag@psy.vu.nl
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study